Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 3
1977 2
1979 1
1982 1
1983 1
1984 1
1985 2
1986 1
1987 1
1988 1
1990 2
1991 4
1992 2
1993 2
1994 3
1995 1
1996 4
1998 1
2000 1
2001 1
2002 2
2003 7
2004 8
2005 4
2006 11
2007 23
2008 22
2009 24
2010 21
2011 49
2012 56
2013 58
2014 66
2015 90
2016 78
2017 74
2018 99
2019 128
2020 160
2021 195
2022 195
2023 175
2024 65

Text availability

Article attribute

Article type

Publication date

Search Results

1,419 results

Results by year

Filters applied: . Clear all
Page 1
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states.
Dräger NM, Sattler SM, Huang CT, Teter OM, Leng K, Hashemi SH, Hong J, Aviles G, Clelland CD, Zhan L, Udeochu JC, Kodama L, Singleton AB, Nalls MA, Ichida J, Ward ME, Faghri F, Gan L, Kampmann M. Dräger NM, et al. Among authors: hashemi sh. Nat Neurosci. 2022 Sep;25(9):1149-1162. doi: 10.1038/s41593-022-01131-4. Epub 2022 Aug 11. Nat Neurosci. 2022. PMID: 35953545 Free PMC article.
Parallel CRISPR-Cas9 screens identify mechanisms of PLIN2 and lipid droplet regulation.
Roberts MA, Deol KK, Mathiowetz AJ, Lange M, Leto DE, Stevenson J, Hashemi SH, Morgens DW, Easter E, Heydari K, Nalls MA, Bassik MC, Kampmann M, Kopito RR, Faghri F, Olzmann JA. Roberts MA, et al. Among authors: hashemi sh. Dev Cell. 2023 Sep 25;58(18):1782-1800.e10. doi: 10.1016/j.devcel.2023.07.001. Epub 2023 Jul 25. Dev Cell. 2023. PMID: 37494933 Free article.
Exosome engineering in cell therapy and drug delivery.
Sadeghi S, Tehrani FR, Tahmasebi S, Shafiee A, Hashemi SM. Sadeghi S, et al. Among authors: hashemi sm. Inflammopharmacology. 2023 Feb;31(1):145-169. doi: 10.1007/s10787-022-01115-7. Epub 2023 Jan 7. Inflammopharmacology. 2023. PMID: 36609717 Free PMC article. Review.
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis.
Planchard D, Besse B, Groen HJM, Hashemi SMS, Mazieres J, Kim TM, Quoix E, Souquet PJ, Barlesi F, Baik C, Villaruz LC, Kelly RJ, Zhang S, Tan M, Gasal E, Santarpia L, Johnson BE. Planchard D, et al. Among authors: hashemi sms. J Thorac Oncol. 2022 Jan;17(1):103-115. doi: 10.1016/j.jtho.2021.08.011. Epub 2021 Aug 26. J Thorac Oncol. 2022. PMID: 34455067 Free article. Clinical Trial.
Liquid-Templating Aerogels.
Hashemi SA, Ghaffarkhah A, Goodarzi M, Nazemi A, Banvillet G, Milani AS, Soroush M, Rojas OJ, Ramakrishna S, Wuttke S, Russell TP, Kamkar M, Arjmand M. Hashemi SA, et al. Adv Mater. 2023 Oct;35(42):e2302826. doi: 10.1002/adma.202302826. Epub 2023 Sep 4. Adv Mater. 2023. PMID: 37562445
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC.
Rakaee M, Adib E, Ricciuti B, Sholl LM, Shi W, Alessi JV, Cortellini A, Fulgenzi CAM, Viola P, Pinato DJ, Hashemi S, Bahce I, Houda I, Ulas EB, Radonic T, Väyrynen JP, Richardsen E, Jamaly S, Andersen S, Donnem T, Awad MM, Kwiatkowski DJ. Rakaee M, et al. Among authors: hashemi s. JAMA Oncol. 2023 Jan 1;9(1):51-60. doi: 10.1001/jamaoncol.2022.4933. JAMA Oncol. 2023. PMID: 36394839 Free PMC article.
1,419 results